Management Decisions in Crohn's Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels
克罗恩病的治疗决策会因对肿瘤坏死因子药物水平进行主动和被动检测的知识而改变。
期刊:Crohns Colitis 360
影响因子:2.6
doi:10.1093/crocol/otab042
Wu, Yang; Wen, Amy; Selvanderan, Shane P; Xuan, Wei; Andrews, Jane M; Koo, Jenn H; Williams, Astrid-Jane; Ng, Watson; Connor, Susan
